Pharmaceutical nitrosamine analysis presents an unusual analytical challenge. The impurities of interest may need to be measured at extremely low concentrations, while the analytical sample can contain: a much higher concentration of active pharmaceutical ingredient (API); multiple excipients; process impurities; degradation products; solvents; and other matrix components. This creates two simultaneous requirements: Sensitivity — can […]